Move Fast.
Move Forward.

Delivering synthetic molecular solutions as powerful as they are personalized

Who we are

WuXi Chemistry, a business division of WuXi AppTec, provides contract services for new drug development from discovery to commercial. Our CRDMO model combines CRO, CDMO and CMO services under one roof.

WuXi Chemistry has more than 22,000 employees across 16 research, development and manufacturing sites worldwide, serving more than 2,400 clients from top pharma to virtual biotech. Our services cover all categories for all synthetic molecular modalities, at any material requirement and any scale.

22,000+

Employees worldwide

16

Research, development and manufacturing sites

2,400+

Clients, from top pharma to virtual biotech

Two platforms, one organization

A program run across separate suppliers acquires a technology transfer at each boundary. Every transfer means new analytical methods, a new impurity discussion, a fresh audit, and a period where nobody is accountable for the date.

WuXi Chemistry is organized as two platforms, by modality, because the chemistry behaves differently. Everything either shares — analytical, regulatory, project management, clinical and commercial supply — is run once, for both.

Laboratory analytical services

Shared capabilities

Our locations

Our global network of expertise and cutting-edge facilities is always accessible to guide you forward with precision and insight-led confidence.

View our locations

Product Catalog

Explore our catalog to discover high-quality building blocks, intermediates, and research tools designed to support complex small molecule, peptide, and oligonucleotide development and manufacturing.

View our product catalog

Our Commitment to ESG 

We’re not just committed to innovating better medicines today, but to pioneering a more sustainable tomorrow.

Our commitment to environmental stewardship, social responsibility and ethical governance guides our operations and helps all of us propel the industry forward to a greener, more equitable future.

Learn more
Skip to toolbar